PMID- 21289263 OWN - NLM STAT- MEDLINE DCOM- 20110614 LR - 20140730 IS - 1945-7197 (Electronic) IS - 0021-972X (Linking) VI - 96 IP - 4 DP - 2011 Apr TI - The effect of very-low-calorie diet on mRNA expression of inflammation-related genes in subcutaneous adipose tissue and peripheral monocytes of obese patients with type 2 diabetes mellitus. PG - E606-13 LID - 10.1210/jc.2010-1858 [doi] AB - CONTEXT: Low-grade inflammation links obesity, type 2 diabetes mellitus (T2DM), and cardiovascular diseases. OBJECTIVE: To explore the expression profile of genes involved in inflammatory pathways in adipose tissue and peripheral monocytes (PM) of obese patients with and without T2DM at baseline and after dietary intervention. DESIGN: Two-week intervention study with very-low-calorie diet (VLCD). SETTING: University hospital. PATIENTS: Twelve obese females with T2DM, 8 obese nondiabetic females (OB) and 15 healthy age-matched females. INTERVENTION: Two weeks of VLCD (2500 kJ/d). MAIN OUTCOME MEASURES: Metabolic parameters, circulating cytokines, hormones, and mRNA expression of 39 genes in sc adipose tissue (SCAT) and PM. RESULTS: Both T2DM and OB group had significantly increased serum concentrations of circulating proinflammatory factors (C-reactive protein, TNFalpha, IL-6, IL-8), mRNA expression of macrophage antigen CD68 and proinflammatory chemokines (CCL-2, -3, -7, -8, -17, -22) in SCAT and complementary chemokine receptors (CCR-1, -2, -3, -5) and other proinflammatory receptors (toll-like receptor 2 and 4, TNF receptor superfamily 1A and 1B, IL-6R) in PM, with OB group showing less pronounced chemoattracting and proinflammatory profile compared to T2DM group. In T2DM patients VLCD decreased body weight, improved metabolic profile, and decreased mRNA expression of up-regulated CCRs in PM and chemokines [CCL 8, chemokine (C-X-C motif) ligand 10] in SCAT. VLCD markedly increased mRNA expression of T-lymphocyte attracting chemokine CCL-17 in SCAT. CONCLUSION: Obese patients with and without T2DM have increased mRNA expression of chemotactic and proinflammatory factors in SCAT and expression of corresponding receptors in PM. Two weeks of VLCD significantly improved this profile in T2DM patients. FAU - Mraz, M AU - Mraz M AD - Third Department of Medicine, General University Hospital and First Medical Faculty, Charles University, 128 08 Prague 2, Czech Republic. FAU - Lacinova, Z AU - Lacinova Z FAU - Drapalova, J AU - Drapalova J FAU - Haluzikova, D AU - Haluzikova D FAU - Horinek, A AU - Horinek A FAU - Matoulek, M AU - Matoulek M FAU - Trachta, P AU - Trachta P FAU - Kavalkova, P AU - Kavalkova P FAU - Svacina, S AU - Svacina S FAU - Haluzik, M AU - Haluzik M LA - eng PT - Controlled Clinical Trial PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20110202 PL - United States TA - J Clin Endocrinol Metab JT - The Journal of clinical endocrinology and metabolism JID - 0375362 RN - 0 (Adipokines) RN - 0 (Chemokines) RN - 0 (Inflammation Mediators) RN - 0 (RNA, Messenger) RN - 0 (Receptors, Adipokine) RN - 0 (Receptors, Chemokine) SB - IM MH - Adipokines/genetics/metabolism MH - *Caloric Restriction MH - Chemokines/genetics/metabolism MH - Diabetes Mellitus, Type 2/blood/complications/*diet therapy/genetics MH - Diet, Reducing MH - Female MH - *Gene Expression Regulation MH - Humans MH - Inflammation/complications/*genetics/metabolism MH - Inflammation Mediators/metabolism MH - Middle Aged MH - Monocytes/*metabolism MH - Obesity/blood/complications/*diet therapy/genetics MH - RNA, Messenger/*genetics/metabolism MH - Receptors, Adipokine/genetics/metabolism MH - Receptors, Chemokine/genetics/metabolism MH - Subcutaneous Fat/*metabolism EDAT- 2011/02/04 06:00 MHDA- 2011/06/15 06:00 CRDT- 2011/02/04 06:00 PHST- 2011/02/04 06:00 [entrez] PHST- 2011/02/04 06:00 [pubmed] PHST- 2011/06/15 06:00 [medline] AID - jc.2010-1858 [pii] AID - 10.1210/jc.2010-1858 [doi] PST - ppublish SO - J Clin Endocrinol Metab. 2011 Apr;96(4):E606-13. doi: 10.1210/jc.2010-1858. Epub 2011 Feb 2.